Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-28

FDA Approved: FELODIPINE — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approves Endo USA, Inc.'s original application for Felodipine (generic), a calcium channel blocker for hypertension and angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Felodipine (felodipine)

Snippet

ORIG AP for FELODIPINE (FELODIPINE)